• Tidak ada hasil yang ditemukan

Author(s): VS/AT

N/A
N/A
Protected

Academic year: 2023

Membagikan "Author(s): VS/AT"

Copied!
2
0
0

Teks penuh

(1)

Author(s): VS/AT Date: 2015-03-12

Question: Should acetaminophen vs placebo be used for reducing vaccine injection pain in people of all ages?

Settings: hospital

Bibliography: Aoki 1993, Chernesky 1993, Doedee 2014, Gross 1994, Heden 2014. Prymula 2009

Quality assessment No of patients Effect

Quality Importance No of

studies Design Risk of

bias Inconsistency Indirectness Imprecision Other

considerations Acetaminophen Placebo Relative

(95%

CI)

Absolute

Pain (measured with: validated tool (Visual Analog Scale, 0-100); Better indicated by lower values) 1 randomised

trials1

no serious risk of bias

no serious inconsistency

serious2 serious3 none 12 14 - SMD 0.64 lower (1.43 lower to 0.15

higher)



LOW

CRITICAL

Fear (measured with: validated tool (Visual Analog Scale 0-100); Better indicated by lower values) 1 randomised

trials1

no serious risk of bias

no serious inconsistency

serious2 serious3 none 12 14 - SMD 0.68 lower (1.48 lower to 0.12

higher)



LOW

IMPORTANT

Distress (measured with: validated tool (Children's Hospital of Eastern Ontario Pain Scale 4-13, Visual Analog Scale 0-100) by nurses, researcher, parent; Better indicated by lower values)

1 randomised trials1

no serious risk of bias

no serious inconsistency

serious2 serious3 none 24 27 - SMD 0.13 lower (0.68 lower to 0.42

higher)



LOW

IMPORTANT4

Safety5 (measured with: validated tool (antibody titres, proportion of individuals with adequate antibody titres); Better indicated by lower values) 5 randomised

trials

none 0 - -5 not pooled5 IMPORTANT

Vaccine Compliance, Preference, Satisfaction (assessed with: no data were identified for these important outcomes)

0 No evidence none - - - - IMPORTANT

(2)

available

0% -

1 Children in both groups received topical anesthetics and children in the intervention group (acetaminophen) received 40mg/kg.

2 Study (Heden 2014) includes children with cancer undergoing needle insertion into a subcutaneously implanted port.

3 Confidence interval crosses the line of nonsignificance and sample size was below the recommended optimum information size (OIS) of 400 for an effect size of 0.2

4 In included study (Heden 2014), 26/51 children were included in this analysis who were able to self-report pain; hence, this outcome was downgraded to an important outcome

5 In 5 included studies (Aoki 1993, Chernesky 1993, Gross 1994, Doedee 2014, Prymula 2009), 3 did not demonstrate an effect and 2 demonstrated a reduction in selected antibody titre levels in the acetaminophen group compared to control. A variety of vaccines and acetaminophen dosing regimens were evaluated in these studies.

 

Referensi

Dokumen terkait

Settings: clinics Bibliography: Morelius 2009 3,4 Quality assessment No of patients Effect Quality Importance No of studies Design Risk of bias Inconsistency Indirectness

1 randomised trials serious5 no serious inconsistency no serious indirectness serious9 none 33 33 - SMD 0.21 lower 0.7 lower to 0.27 higher  LOW IMPORTANT Safety assessed

Settings: clinics hospital and outpatient Bibliography: Gonzalez 1993 2, Manimala 2000 2 Quality assessment No of patients Effect Quality Importance No of studies Design Risk

Settings: clinic Bibliography: Gonzalez 1993 1, O'Laughlin 1995 1 Quality assessment No of patients Effect Quality Importance No of studies Design Risk of bias

Settings: hospital Bibliography: Chermont 2009 1,2, Kostandy 2013 2008 thesis, Saeidi 2011 Quality assessment No of patients Effect Quality Importance No of studies Design Risk of

Settings: clinic Bibliography: Hallstrom 1968, Ipp 2004, Taavoni 2010 Quality assessment No of patients Effect Quality Importance No of studies Design Risk of bias Inconsistency

Settings: dental clinic, MS clinic Bibliography: Heaton 2013, Mohr 2005 Quality assessment No of patients Effect Quality Importance No of studies Design Risk of bias

Quality assessment for BMI-stratified dosing regimens using GRADE methodology Number of Studies Study design Limitations Inconsistency Indirectness Imprecision Other considerations